Is Estrella Immunopharma, Inc. (ESLA) a Buy, Sell, or Hold?
NASDAQ : ESLA
Estrella Immunopharma, Inc. — Competitors
$0.7505 USD
-$0.03 (-3.78%)
- Volume
- 8.96K
- Average Volume
- 41.72K
- Market Capitalization
- $32.3M
- P/E Ratio
- -2.17
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $3.15
- Year Low
- $0.73
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.24
ESLA vs. The Competition
| Properties | ESLA | ANEB | ATOS | EXOZ |
|---|---|---|---|---|
| Market Cap | $32.3M | $12.24M | $23.94M | $41.95M |
| Shares Outstanding | $43.03M | $40.78M | $9.98M | $9.28M |
| P/E Ratio | -2.17 | -1.54 | -0.55 | -3.93 |
| EPS | -0.31 | -0.19 | -4.37 | -1.14 |
| Day Low | 0.75 | 0.3 | 2.3 | 4.52 |
| Day High | 0.7801 | 0.8699 | 2.4 | 5.01 |
| Year Low | 0.73 | 0.001 | 1.7 | 4.52 |
| Year High | 3.15 | 3.2 | 19.35 | 18.4 |
| Average Price 50 | 1.00602 | 0.39194 | 3.2814 | 7.9763 |
| Average Price 200 | 1.40783 | 1.09698 | 7.30215 | 10.42173 |
| Volume | 8965.0 | 100 | 28715 | 9541.06 |
| Average Volume | - | - | - | - |